Invention Grant
US08389566B2 Prostaglandins and analogues as agents for lowering intraocular pressure
有权
前列腺素和类似物作为降低眼内压的药物
- Patent Title: Prostaglandins and analogues as agents for lowering intraocular pressure
- Patent Title (中): 前列腺素和类似物作为降低眼内压的药物
-
Application No.: US12971221Application Date: 2010-12-17
-
Publication No.: US08389566B2Publication Date: 2013-03-05
- Inventor: Robert M. Burk
- Applicant: Robert M. Burk
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Kevin J. Forrestal; John E. Wurst; Doina G. Ene
- Main IPC: A61K31/38
- IPC: A61K31/38 ; A61K31/34
Abstract:
The present invention relates to cyclopentane heptenoic acid-5-cis-2-(3α-hydroxy or lower alkyloxy-5-thienylpentyl)-3, 5-dihydroxy, [1α, 2β, 3α, 5α] compounds, lower alkyl, hydroxyl lower alkyl and indole lower alkyl amides and esters thereof as potent ocular hypotensives that are particularly suited for the management of glaucoma.
Public/Granted literature
- US20110152797A1 PROSTAGLANDINS AND ANALOGUES AS AGENTS FOR LOWERING INTRAOCULAR PRESSURE Public/Granted day:2011-06-23
Information query
